» Articles » PMID: 36542641

Availability, Price, and Affordability of Medicines Used for the Management of Covid-19 in Health Facilities of Dessie Town WHO/HAI Survey

Overview
Journal PLoS One
Date 2022 Dec 21
PMID 36542641
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The rapidly spreading nature of Covid-19 virus associated with its high mortality and mortality rate is triggering an unprecedented public health crisis. The study assessed the availability, price, and affordability of medicines used in the management of Covid-19 in health facilities of Dessie town.

Methods: A retrospective cross-sectional study design was employed in the health facilities of Dessie town from September 1 to September 20, 2021. Data was collected using a standard checklist adopted from the Logistics Indicator Assessment Tool and WHO/HAI. WHO/HAI methodology was applied to select the surveyed health facilities (30) and medicines (44). The daily wage of the lowest-paid unskilled government worker is used to estimate affordability.

Results: Fifteen and five medicines were not found at all public and private health facilities, respectively. The originator brand (OB) and lowest price generic (LPG) availability in private health facilities was 2.03% and 51.33%, respectively. In the public sector, the availability of OB and LPG was 0% and 34.44%, respectively. In public and private health facilities, the mean number of stock-outs was 2.25 and 2.91, and the mean number of stock-out days was 177.83 and 106.16 days, respectively. Eight and one LPG medicines were out of stock in public and private health facilities, respectively. Eight (33.33%) and 6 (28.57%) had higher prices than international prices in private and public health facilities, respectively. The median price ratio in public and private health facilities ranged from 0.02 and 3.05 and 0.04 to 2.70, respectively. Eighty percent of the products were unaffordable in both sectors.

Conclusions: The availability of medicines was low. One-third of the medicines had higher prices than international prices. Eighty percent of the products were unaffordable. The regular supply of these medicines is crucial for better management of the disease.

References
1.
Haque M, Kumar S, Charan J, Bhatt R, Islam S, Dutta S . Utilisation, Availability and Price Changes of Medicines and Protection Equipment for COVID-19 Among Selected Regions in India: Findings and Implications. Front Pharmacol. 2021; 11:582154. PMC: 7898674. DOI: 10.3389/fphar.2020.582154. View

2.
Kefale A, Shebo H . Availability of essential medicines and pharmaceutical inventory management practice at health centers of Adama town, Ethiopia. BMC Health Serv Res. 2019; 19(1):254. PMC: 6485132. DOI: 10.1186/s12913-019-4087-0. View

3.
Konnopka A, Konig H . Economic Burden of Anxiety Disorders: A Systematic Review and Meta-Analysis. Pharmacoeconomics. 2019; 38(1):25-37. DOI: 10.1007/s40273-019-00849-7. View

4.
Yang C, Hu S, Ye D, Jiang M, Babar Z, Fang Y . Evaluating Price and Availability of Essential Medicines in China: A Mixed Cross-Sectional and Longitudinal Study. Front Pharmacol. 2020; 11:602421. PMC: 7768899. DOI: 10.3389/fphar.2020.602421. View

5.
Bilal A, Osman E, Mulugeta A . Assessment of medicines use pattern using World Health Organization's Prescribing, Patient Care and Health facility indicators in selected health facilities in eastern Ethiopia. BMC Health Serv Res. 2016; 16:144. PMC: 4841957. DOI: 10.1186/s12913-016-1414-6. View